Muraleedharan T, Ammineni K, Shah P, Srijamya. Residual Inflammatory Risk in Atherosclerotic Cardiovascular Disease: Is Anti-Inflammatory Therapy the Next Frontier Beyond LDL Reduction?. Int J Med Stud [Internet]. 2026 Aug. 19 [cited 2026 Aug. 30];. Available from: https://ijms.info/IJMS/article/view/4839